BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28673797)

  • 1. Management of Clinical Stage I Nonseminomatous Germ Cell Testicular Tumors: A 25-year Single-center Experience.
    Ondrusova M; Waczulikova I; Lehotska V; Zeleny T; Ondrus D
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1015-e1019. PubMed ID: 28673797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
    Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
    Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversies in the management of clinical stage I nonseminomatous germ cell testicular cancer.
    Ondrus D; Kajo K; Stastna V; Ondrusova M
    Klin Onkol; 2015; 28(2):112-5. PubMed ID: 25882021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of patients with clinical stage I nonseminomatous germ cell testicular cancer: Active surveillance versus adjuvant chemotherapy - single-centre experience.
    Ondrus D; Ondrusova M; Kajo K
    Neoplasma; 2015; 62(1):159-63. PubMed ID: 25023569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Risk-adapted Surveillance vs Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: A Retrospective Follow-up Study of 81 Patients.
    Fan G; Zhang L; Yi L; Jiang ZQ; Ke Y; Wang XS; Xiong YY; Han WQ; Zhou X; Liu C; Yu X
    Asian Pac J Cancer Prev; 2015; 16(8):3267-72. PubMed ID: 25921130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy.
    Kollmannsberger C; Moore C; Chi KN; Murray N; Daneshmand S; Gleave M; Hayes-Lattin B; Nichols CR
    Ann Oncol; 2010 Jun; 21(6):1296-1301. PubMed ID: 19875756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in clinical stage I nonseminomatous germ cell testicular tumors: rationale for different risk-adapted treatment.
    Ondrus D; Matoska J; Belan V; Kausitz J; Goncalves F; Hornák M
    Eur Urol; 1998; 33(6):562-6. PubMed ID: 9743698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors (NSGCTT).
    Ondrus D; Goncalves F; Kausitz J; Mat'oska J; Belan V
    Neoplasma; 1996; 43(3):195-7. PubMed ID: 8841507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
    Gumus M; Bilici A; Odabas H; Ustaalioglu BBO; Kandemir N; Demirci U; Cihan S; Bayoglu IV; Ozturk T; Turkmen E; Urakci Z; Seker MM; Gunaydin Y; Selcukbiricik F; Turan N; Sevinc A
    World J Urol; 2017 Jul; 35(7):1103-1110. PubMed ID: 27812752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
    Divrik RT; Akdoğan B; Ozen H; Zorlu F
    J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active surveillance as a successful management strategy for patients with clinical stage I germ cell testicular cancer.
    Escudero-Ávila R; Rodríguez-Castaño JD; Osman I; Fernandez F; Medina R; Vargas B; Japón-Rodríguez M; Sancho P; Perez-Valderrama B; Praena-Fernández JM; Duran I
    Clin Transl Oncol; 2019 Jun; 21(6):796-804. PubMed ID: 30470992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late relapse in stage I of nonseminomatous germ cell testicular cancer on surveillance.
    Ondrusova M; Suchansky M; Psota M; Zeleny T; Ondrus D
    Bratisl Lek Listy; 2018; 119(1):3-5. PubMed ID: 29405722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orchiectomy alone for clinical stage I nonseminomatous germ cell tumors of the testis (NSGCTT): a minimum follow-up period of 5 years.
    Ondrus D; Hornak M
    Tumori; 1994 Oct; 80(5):362-4. PubMed ID: 7839467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
    Heidenreich A; Pfister D
    Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage I nonseminomatous germ cell tumor of the testis: more questions than answers?
    Powles T
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):517-27,viii. PubMed ID: 21570606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.
    Sturgeon JF; Moore MJ; Kakiashvili DM; Duran I; Anson-Cartwright LC; Berthold DR; Warde PR; Gospodarowicz MK; Alison RE; Liu J; Ma C; Pond GR; Jewett MA
    Eur Urol; 2011 Apr; 59(4):556-62. PubMed ID: 21190791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for patients with clinical stage I nonseminomatous testicular germ cell tumors.
    Li X; Guo S; Wu Z; Dong P; Li Y; Zhang Z; Yao K; Han H; Qin Z; Zhou F; Liu Z
    World J Urol; 2015 Sep; 33(9):1351-7. PubMed ID: 25471669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for relapse in patients with clinical stage I testicular nonseminomatous germ cell tumors.
    Dong P; Liu ZW; Li XD; Li YH; Yao K; Wu S; Qin ZK; Han H; Zhou FJ
    Med Oncol; 2013 Mar; 30(1):494. PubMed ID: 23400963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.